Home » Novartis to Add Warnings to Rasilez Blood-Pressure Drug
Novartis to Add Warnings to Rasilez Blood-Pressure Drug
Novartis AG said it will add a warning to the label for its blood-pressure drug Rasilez in Europe to comply with a request from regulators.
Bloomberg
Bloomberg
Upcoming Events
-
07May
-
14May
-
30May